Latest News

For teams struggling to transform random ideas into actionable plans, the significance of AI mind-mapping tools continues to grow. No longer will teams need to manually organize every thought; AI can now create maps from prompts, meeting notes, research results, project briefs, or workshop inputs. This is a benefit for making mind mapping quicker; however, [...]

With geopolitical, inflation, and AI spending risks growing, investors are already pivoting toward higher-quality stocks in 2026.

VT covers some 10,000 stocks worldwide, while SPDW focuses on developed markets ex-US with around 2,000 holdings but a higher yield.

Berkshire Hathaway is ready for a market downturn, but its safe pile of cash is increasingly a valuable asset in and of itself.

As AI software multiples compress, institutional capital is rotating into aviation, space, and energy hardware stocks including JOBY, RKLB, LUNR, ASTS, and FCEL.

This REIT has already made early investors rich.

This specialty REIT, focused on experiential real estate, reported a notable insider sale amid a year of double-digit share price gains.

Nebius and CoreWeave are rapidly growing.

This downtrend is an opportunity for those who are patient.

This AI stock still trades at a deep discount to its peers.

Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026.

A $100,000 TFSA isn’t a finish line, it’s what can happen when contributions are invested instead of left in cash.

Cập nhật HitClub 2026 với những thông tin mới về ứng dụng, phiên bản mới và các nội dung nổi bật đang được nhiều người quan tâm. Người dùng có thể khám phá

Sandisk has dominated the S&P 500 so far this year.

These Canadian stocks are most likely to maintain and grow their dividends over time, providing reliable passive income.

D.R. Horton beat Q2 estimates with $7.6 billion in revenue, raised full-year guidance, and returned over $1 billion to shareholders, even as new home demand remains under pressure.

Targeted therapies meet AI-driven discovery as these biotech innovators reveal sharply contrasting financials, risk factors, and industry partnerships.

Broad healthcare diversification or concentrated biotech growth? Compare cost, risk, and portfolio composition to find your fit.

iShares Semiconductor ETF delivered 153.6% returns over one year, outpacing Roundhill's AI-focused fund despite higher volatility and a steeper drawdown.

There is one important lesson from the geopolitical conflict in the Middle East: Energy is still vital to the world.

Dollar-cost average into a Canadian high‑yield dividend ETF for simple, tax‑free TFSA income.

Don't let yourself get caught off guard.

A rapidly approaching accelerated lockup period will allow SpaceX insiders to cash out at the expense of retail investors.

This genomic diagnostics company saw a notable insider sale, as shares have surged over 70% in the past year.

It's underperforming the market.